Adjuvant chemotherapy in elderly patients: An analysis of national cancer institute of Canada clinical trials group and intergroup JBR.10

被引：0
|
作者：
Pepe, C.
Hasan, B.
Winton, T.
Seymour, L.
Pater, J.
Livingston, R.
Johnson, D.
Rigas, J.
Ding, K.
Shepherd, F. A.
机构：
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2006年 / 60卷
关键词：
D O I：
10.1016/S1040-8428(13)70021-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S6 / S7
页数：2
相关论文
共 50 条
  • [21] Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: The JBR.10 trial experience
    Gauthier, I.
    Ding, K.
    Winton, T.
    Shepherd, F. A.
    Livingston, R.
    Johnson, D. H.
    Rigas, J. R.
    Whitehead, M.
    Graham, B.
    Seymour, L.
    LUNG CANCER, 2007, 55 (03) : 357 - 363
  • [22] TESTING HYPOTHESES IN CLINICAL-TRIALS - EXPERIENCE OF THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP
    PATER, JL
    EISENHAUER, E
    SHELLEY, W
    WILLAN, AR
    CANCER TREATMENT REPORTS, 1986, 70 (09): : 1133 - 1136
  • [23] Evaluating health-related quality of life in cancer clinical trials: The National Cancer Institute of Canada Clinical Trials Group experience
    Osoba, David
    Bezjak, Andrea
    Brundage, Michael
    Pater, Joseph
    VALUE IN HEALTH, 2007, 10 : S138 - S145
  • [24] Class III β-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer:: Analysis of NCIC JBR.10
    Seve, Pascal
    Lai, Raymond
    Ding, Keyue
    Winton, Timothy
    Butts, Charles
    Mackey, John
    Dumontet, Charles
    Dabbagh, Laith
    Aviel-Ronen, Sarit
    Seymour, Lesley
    Whitehead, Marlo
    Tsao, Ming-Sound
    Shepherd, Frances A.
    Reiman, Tony
    CLINICAL CANCER RESEARCH, 2007, 13 (03) : 994 - 999
  • [25] Quality of life (QOL) impact of adjuvant chemotherapy for early stage non- small cell lung cancer (NSCLC): Final analysis of JBR.10 randomized trial
    Bezjak, A.
    Lee, C. W.
    Ding, K.
    Winton, T.
    Brundage, M.
    Graham, B.
    Whitehead, M.
    Seymour, L.
    Shepherd, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] Phase I clinical study of didemnin B -: A National Cancer Institute of Canada clinical trials group study
    Maroun, JA
    Stewart, D
    Verma, S
    Eisenhauer, E
    INVESTIGATIONAL NEW DRUGS, 1998, 16 (01) : 51 - 56
  • [27] Erlotinib for advanced non-small-cell lung cancer in the elderly: An analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21
    Wheatley-Price, Paul
    Ding, Keyue
    Seymour, Lesley
    Clark, Gary M.
    Shepherd, Frances A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (14) : 2350 - 2357
  • [28] A clinical prognostic index for patients treated with erlotinib in National Cancer Institute of Canada clinical trials group study BR.21
    Florescu, Marie
    Hasan, Baktiar
    Seymour, Lesley
    Ding, Keyue
    Shepherd, Frances A.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) : 590 - 598
  • [29] Phase II trial of docetaxel in patients with recurrent malignant glioma: A study of the National Cancer Institute of Canada Clinical Trials group
    Forsyth, P
    Cairncross, G
    Stewart, D
    Goodyear, M
    Wainman, N
    Eisenhauer, E
    INVESTIGATIONAL NEW DRUGS, 1996, 14 (02) : 203 - 206
  • [30] Venous thromboembolism and non-small cell lung cancer: A pooled analysis of National Cancer Institute of Canada Clinical Trials Group (NCIC CTC) trials
    Hicks, Lisa
    Cheung, Matthew
    Hasan, Baktiar
    Ding, Keyue
    Seymour, Lesley
    Leighl, Natasha B.
    Winton, Timothy L.
    Shepherd, Frances A.
    BLOOD, 2007, 110 (11) : 67B - 67B
12345